ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3034% above fair value
$179.27+1.97 (+1.11%)
Close on Nov 13, 2026Market cap $4.48BP/E 74.4Yield –
ICU Medical r&d expenses
Research and development expenses are spending on new products and technology.
ICU Medical's R&D Expenses for the twelve months ending Sep 30, 2026 was $86.82M, down 2.2% year over year. For fiscal 2025 it was $87.50M, down 1.3% from the year before. Over ten years it grew 18.7% a year on average. The highest annual figure on record is $92.98M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.50M | -1.3% |
| FY2024 | Dec 31, 2024 | $88.62M | +3.8% |
| FY2023 | Dec 31, 2023 | $85.34M | -8.2% |
| FY2022 | Dec 31, 2022 | $92.98M | +95.8% |
| FY2021 | Dec 31, 2021 | $47.50M | +10.6% |
| FY2020 | Dec 31, 2020 | $42.95M | -11.6% |
| FY2019 | Dec 31, 2019 | $48.61M | -8.1% |
| FY2018 | Dec 31, 2018 | $52.87M | +3.1% |
| FY2017 | Dec 31, 2017 | $51.25M | +295.6% |
| FY2016 | Dec 31, 2016 | $12.96M | -17.6% |
| FY2015 | Dec 31, 2015 | $15.71M | -14.3% |
| FY2014 | Dec 31, 2014 | $18.33M | +47.8% |
| FY2013 | Dec 31, 2013 | $12.41M | +16.7% |
| FY2012 | Dec 31, 2012 | $10.63M | +23.8% |
| FY2011 | Dec 31, 2011 | $8.59M | +83.6% |
| FY2010 | Dec 31, 2010 | $4.68M | +76.9% |
| FY2009 | Dec 31, 2009 | $2.65M | -45.1% |
| FY2008 | Dec 31, 2008 | $4.82M | -40.5% |
| FY2007 | Dec 31, 2007 | $8.11M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $21.75M | +2.4% |
| Q2 FY2026 | Jun 30, 2026 | $22.70M | +3.8% |
| Q1 FY2026 | Mar 31, 2026 | $21.28M | -8.6% |
| Q4 FY2025 | Dec 31, 2025 | $21.09M | -5.7% |
| Q3 FY2025 | Sep 30, 2025 | $21.25M | +1.1% |
| Q2 FY2025 | Jun 30, 2025 | $21.87M | -6.5% |
| Q1 FY2025 | Mar 31, 2025 | $23.29M | +6.6% |
| Q4 FY2024 | Dec 31, 2024 | $22.36M | -0.2% |
| Q3 FY2024 | Sep 30, 2024 | $21.03M | +0.8% |
| Q2 FY2024 | Jun 30, 2024 | $23.39M | +4.9% |
| Q1 FY2024 | Mar 31, 2024 | $21.84M | +10.5% |
| Q4 FY2023 | Dec 31, 2023 | $22.41M | -4.4% |
| Q3 FY2023 | Sep 30, 2023 | $20.87M | -9.7% |
| Q2 FY2023 | Jun 30, 2023 | $22.30M | -1.2% |
| Q1 FY2023 | Mar 31, 2023 | $19.76M | -17.2% |
| Q4 FY2022 | Dec 31, 2022 | $23.45M | +78.1% |
| Q3 FY2022 | Sep 30, 2022 | $23.11M | +88.8% |
| Q2 FY2022 | Jun 30, 2022 | $22.56M | +98.2% |
| Q1 FY2022 | Mar 31, 2022 | $23.87M | +122.9% |
| Q4 FY2021 | Dec 31, 2021 | $13.17M | +11.6% |
| Q3 FY2021 | Sep 30, 2021 | $12.24M | +20.9% |
| Q2 FY2021 | Jun 30, 2021 | $11.39M | +10.8% |
| Q1 FY2021 | Mar 31, 2021 | $10.71M | -0.3% |
| Q4 FY2020 | Dec 31, 2020 | $11.80M | -6.3% |
| Q3 FY2020 | Sep 30, 2020 | $10.13M | -15.6% |
| Q2 FY2020 | Jun 30, 2020 | $10.28M | -8.2% |
| Q1 FY2020 | Mar 31, 2020 | $10.75M | -16.2% |
| Q4 FY2019 | Dec 31, 2019 | $12.59M | -6.9% |
| Q3 FY2019 | Sep 30, 2019 | $12.00M | -8.9% |
| Q2 FY2019 | Jun 30, 2019 | $11.20M | -17.5% |
| Q1 FY2019 | Mar 31, 2019 | $12.82M | +1.9% |
| Q4 FY2018 | Dec 31, 2018 | $13.53M | -2.5% |
| Q3 FY2018 | Sep 30, 2018 | $13.18M | +3.2% |
| Q2 FY2018 | Jun 30, 2018 | $13.58M | +4.7% |
| Q1 FY2018 | Mar 31, 2018 | $12.59M | +8.1% |
| Q4 FY2017 | Dec 31, 2017 | $13.88M | +422.8% |
| Q3 FY2017 | Sep 30, 2017 | $12.77M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.97M | – |
| Q1 FY2017 | Mar 31, 2017 | $11.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.65M | – |
See a number that looks wrong?